Piramal Pharma Limited (BOM:543635)
India · Delayed Price · Currency is INR 200.05
+5.15 (2.64%)
At close: Oct 6, 2026
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 269.85 billion as of October 7, 2026. Its market cap has increased by 2.40% in one year.
Market Cap
269.85B
Enterprise Value
313.42B
Revenue
92.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
200.05
ChartMarket Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 269.85B, an increase of 19.02%. That is a compound annual growth rate of 4.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 266.54B | 16.56% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lupin | 930.47B |
| Abbott India | 555.22B |
| GlaxoSmithKline Pharmaceuticals | 467.24B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 207.20B |
| Caplin Point Laboratories | 197.91B |
| Jubilant Pharmova | 155.30B |
| AstraZeneca Pharma India | 147.83B |